KR102353048B1 - Black garlic extract, black garlic drink comprising it and composition for improving male health comprising it - Google Patents

Black garlic extract, black garlic drink comprising it and composition for improving male health comprising it Download PDF

Info

Publication number
KR102353048B1
KR102353048B1 KR1020190104204A KR20190104204A KR102353048B1 KR 102353048 B1 KR102353048 B1 KR 102353048B1 KR 1020190104204 A KR1020190104204 A KR 1020190104204A KR 20190104204 A KR20190104204 A KR 20190104204A KR 102353048 B1 KR102353048 B1 KR 102353048B1
Authority
KR
South Korea
Prior art keywords
black garlic
black
extract
cells
composition
Prior art date
Application number
KR1020190104204A
Other languages
Korean (ko)
Other versions
KR20210024726A (en
Inventor
신정혜
강민정
김동규
강재란
차건수
조아로
Original Assignee
(재)남해마늘연구소
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (재)남해마늘연구소 filed Critical (재)남해마늘연구소
Priority to KR1020190104204A priority Critical patent/KR102353048B1/en
Publication of KR20210024726A publication Critical patent/KR20210024726A/en
Application granted granted Critical
Publication of KR102353048B1 publication Critical patent/KR102353048B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/02Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
    • A23L2/04Extraction of juices
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L19/00Products from fruits or vegetables; Preparation or treatment thereof
    • A23L19/10Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L21/00Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
    • A23L21/20Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/31Foods, ingredients or supplements having a functional effect on health having an effect on comfort perception and well-being
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2300/00Processes
    • A23V2300/14Extraction

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

본 발명은 흑마늘 추출물, 이를 포함하는 흑마늘 음료 및 남성 건강증진용 조성물에 관한 것으로, 보다 상세하게는 총 페놀화합물과 SAC의 함량이 높은 흑마늘 추출물과, 이를 포함하는 흑마늘 음료, 및 흑마늘 추출물에 흑삼 추출물 또는 흑삼 분말을 혼합함으로써 각각이 지니는 활성에 비해 더 높은 활성을 지니는 남성 건강증진용 조성물을 개시한다.The present invention relates to a black garlic extract, a black garlic drink containing the same, and a composition for promoting men's health, and more particularly, to a black garlic extract having a high content of total phenolic compounds and SAC, a black garlic drink containing the same, and a black ginseng extract to the black garlic extract Or, by mixing black ginseng powder, a composition for promoting men's health having a higher activity than that of each is disclosed.

Description

흑마늘 추출물, 이를 포함하는 흑마늘 음료 및 남성 건강증진용 조성물{Black garlic extract, black garlic drink comprising it and composition for improving male health comprising it}Black garlic extract, black garlic drink comprising the same, and a composition for improving men's health {Black garlic extract, black garlic drink comprising it and composition for improving male health comprising it}

본 발명은 흑마늘 추출물, 이를 포함하는 흑마늘 음료 및 남성 건강증진용 조성물에 관한 것으로, 보다 상세하게는 총 페놀화합물과 SAC의 함량이 높은 흑마늘 추출물과, 이를 포함하는 흑마늘 음료, 및 흑마늘 추출물에 흑삼 추출물 또는 흑삼 분말을 혼합함으로써 각각이 지니는 활성에 비해 더 높은 활성을 지니는 남성 건강증진용 조성물에 관한 것이다.The present invention relates to a black garlic extract, a black garlic drink containing the same, and a composition for promoting men's health, and more particularly, to a black garlic extract having a high content of total phenolic compounds and SAC, a black garlic drink containing the same, and a black ginseng extract to the black garlic extract Or by mixing black ginseng powder, it relates to a composition for promoting men's health having a higher activity than the activity each has.

흑마늘은 생마늘을 80~90℃의 온도에서 장시간 숙성시키는 과정 중 비효소적 갈변 반응에 의해 진한 흑색으로 나타나는데, 이러한 기작은 갈색 물질인 melanoidins의 환원성 성분에 의해 유리 라디칼의 제거 및 함질소 화합물에 의한 질소 원자의 유리전자대로부터 proton의 이동작용에 따른 것으로 고온에서 장시간 노출되어 마이얄 반응에 의해 생성된 갈색 물질이 모여 흑색을 띄게 된다. Black garlic appears dark black due to a non-enzymatic browning reaction during the long-term aging of raw garlic at a temperature of 80~90℃. It is due to the movement of protons from the free electron band of nitrogen atoms, and when exposed to high temperatures for a long time, the brown substances produced by the Maillard reaction gather and appear black.

흑마늘은 마늘 특유의 강한 맛과 자극적인 냄새가 제거되고 당류가 분해되어 유기산과 어우러져 새콤달콤한 맛을 지니며 젤리와 유사한 식감을 가져 생마늘에 비해 섭취에 유리한 장점을 가진다. 또한, 숙성 과정에서 식물체 내에 존재하는 대표적인 기능성 성분인 폴리페놀 화합물의 함량이 증가되며, 수용성 유황화합물인 S-allylcysteine (SAC)은 항산화, 암세포 증식억제, 인지기능 향상, 간 보호 등의 기능성이 있다. 따라서 흑마늘은 페놀화합물과 SAC로부터 유래하는 기능성과 더불어 마늘 고유의 활성인 혈중 지질농도 개선, 혈중 콜레스테롤 감소, 피로회복, 지구력 증진 등의 기능성을 가지는 것으로 알려져 있다.Black garlic has a sweet and sour taste in harmony with organic acids as the strong taste and irritating odor unique to garlic are removed, sugars are decomposed, and it has a texture similar to jelly, so it has advantages in consumption compared to raw garlic. In addition, during the aging process, the content of polyphenol compounds, a representative functional component present in plants, is increased, and S-allylcysteine (SAC), a water-soluble sulfur compound, has functions such as antioxidant, inhibition of cancer cell proliferation, improvement of cognitive function, and liver protection. . Therefore, black garlic is known to have functionalities derived from phenolic compounds and SAC, as well as functions such as improvement of blood lipid concentration, reduction of blood cholesterol, recovery from fatigue, and improvement of endurance, which are the intrinsic activities of garlic.

흑삼은 수회 증숙 및 건조과정을 거쳐 인삼의 색이 검게 변한 것으로 기본적으로 인삼에 존재하던 사포닌이 소실되지 않을 뿐만 아니라, 가공된 인삼에만 존재하는 인삼 사포닌의 함량은 더 증가되는 것으로 알려져 있다. 그 중 대표적인 성분인 ginsenoside Rg3는 뇌신경보호, 항암, 면역증강작용, 비만억제 등 많은 생리활성을 가지는 성분으로 알려져 있으며, 그 함량이 수삼 또는 홍삼에 비하여 증가되어 있는 차별화된 특징을 가진다.Black ginseng has undergone several steaming and drying processes to change the color of ginseng to black. Basically, it is known that the saponin present in ginseng is not lost, and the content of ginseng saponin present only in processed ginseng is further increased. Among them, ginsenoside Rg3, a representative component, is known as a component having many physiological activities such as brain neuroprotection, anticancer, immune enhancement, and obesity suppression, and its content is increased compared to fresh ginseng or red ginseng.

흑마늘과 흑삼은 제조 공정에는 차이가 있으나 동일하게 열처리 공정을 거치면서 자체 성분에 함유되어 있던 아미노산과 당류가 반응하여 갈변물질을 다량 생성함으로써 색이 검게 변한 대표적인 블랙푸드 이다. 이들 모두 여러 기능성을 가지는 식품임이 여러 연구들을 통해서 이미 입증되고 있다.Although black garlic and black ginseng have differences in the manufacturing process, they are representative black food that turns black by the reaction of amino acids and sugars contained in its own ingredients through the same heat treatment process to produce a large amount of browning substances. It has already been proven through several studies that all of these are foods with various functions.

하지만, 흑마늘은 마늘 특유의 향이 잔존하고 있으며, 자체 성분에 당류가 많아 보관 중 굳어지는 현상이 발생하므로 100% 분말로 이용하는 데는 한계를 지녀 주로 흑마늘 자체로 소비되거나 추출액의 형태로 음용되고 있다. However, black garlic has a unique flavor of garlic, and there are many sugars in its ingredients, which causes it to harden during storage, so there is a limit to using it as a 100% powder.

흑삼은 인삼 특유의 향이 잔존하고, 쓴맛이 강하여 단독을 추출할 경우 음용에 어려움이 있으며, 농도가 높을수록 쓴맛이 강한 특성이 있다. 또한, 분말로 이용할 경우 쓴맛이 제거되지 않으며, 흑마늘에 비해 상대적으로 당분이 적어 분말화는 유리하지만 홍삼보다도 많은 공정을 거침으로 인해 단가가 높은 단점이 있다. Black ginseng retains its unique flavor and has a strong bitter taste, making it difficult to drink when extracted alone. The higher the concentration, the stronger the bitter taste. In addition, when used as a powder, the bitter taste is not removed, and it has a relatively low sugar content compared to black garlic, so powdering is advantageous, but it has a disadvantage in that the unit price is high because it goes through more processes than red ginseng.

따라서 이 두 소재는 모두 기능성이 우수함이 널리 알려져 있음에도 불구하고, 가공하는 데는 한계를 지니고 있음을 알 수 있다. 이러한 단점을 보완하기 위한 하나의 방법으로 당분이 강한 흑마늘과 쓴맛이 강한 흑삼을 혼합하는 방법을 제안할 수 있다.Therefore, it can be seen that both of these materials have limitations in processing, although they are widely known for their excellent functionality. As one method to compensate for this disadvantage, a method of mixing black garlic with strong sugar and black ginseng with strong bitter taste can be proposed.

흑마늘과 흑(홍)삼을 혼합하여 사용하고자 하는 시도가 이루어진 선행 발명들로 공개특허 10-2009-0068960호에서는 흑마늘 및 홍삼 혼합 추출액 함유 항산화용 건강보조식품 제조방법을 제안함에 있어 생마늘, 흑마늘 및 홍삼 각각을 분쇄한 후 동결건조한 분말에 5배 정도의 물을 가한 후 14시간 동안 진탕배양기에서 상온에서 혼합한 다음 원심분리하여 상층액만을 취하여 항산화활성이 증가된 추출액을 얻는 방법을 제안하고 있다.As prior inventions in which an attempt was made to mix black garlic and black (red) ginseng, Korean Patent Publication No. 10-2009-0068960 proposes a method for preparing a health supplement for antioxidants containing black garlic and red ginseng mixed extract, raw garlic, black garlic and After pulverizing each red ginseng, add about 5 times of water to the freeze-dried powder, mix at room temperature in a shaker incubator for 14 hours, and then centrifuge to obtain an extract with increased antioxidant activity by taking only the supernatant.

생재를 함유하는 흑마늘 추출액의 제조방법(공개특허 10-2018-0136680호)에서는 흑마늘에 3배의 물을 가하여 85~95℃에서 5~10시간 1차 추출한 후 잔사를 다시 추출한 다음 그 잔사액에 작약, 상황, 단삼을 혼합하여 80~95℃에 3~6시간 추출하여 생약재가 혼합된 추출물을 제조함으로써 혈전생성억제, 고지혈증, 고콜레스테롤혈증, 고혈압 등 혈중 지질성분이나 지질대사와 관련하여 개선활성이 있는 흑마늘 추출조성물의 제조방법을 제안하고 있다. In the method for producing a black garlic extract containing raw material (Patent Publication No. 10-2018-0136680), three times the amount of water is added to black garlic and the first extraction is performed at 85-95° C. for 5-10 hours, and then the residue is extracted again, and then in the residue. By mixing peony, mulberry, and dandelion ginseng and extracting at 80~95℃ for 3~6 hours to prepare an extract mixed with herbal medicine, improvement activity in relation to blood lipid components and lipid metabolism such as inhibition of thrombosis, hyperlipidemia, hypercholesterolemia, hypertension, etc. A method for producing a black garlic extract composition is proposed.

등록특허 10-1191980호에서는 흑마늘을 효소를 이용하여 열에 의한 손실을 최소화하면서 유효성분의 함량이 높고 분해 추출 효율이 우수한 흑마늘 추출액의 제조방법을 제안하고 있다. 이 발명에서는 흑마늘과 정제수를 혼합한 후 효소를 첨가하고, 55℃에서 1시간 30분~3시간 동안 분해한 후 95℃에서 10분간 열처리하여 효소를 실활시킨 후 착즙하고, 여과하고 다시 저온 농축하는 공정을 거쳐서 제조하되 3종의 시판 효소를 사용하며, 유효성분이나 추출 효율이 증가되었음에 대한 예시는 제시하지 않고 있다. 이 방법의 경우 0.5%씩 첨가되는 효소로 인해 생산 비용이 증가하며, 효소분해 후 착즙 과정에서 필터의 막힘으로 인해 공정이 원활하지 않을 가능성이 높음을 관련 분야에 통상적인 상식이 있는 경우 짐작할 수 있다. Patent Registration No. 10-1191980 proposes a method for producing a black garlic extract with a high content of active ingredients and excellent decomposition extraction efficiency while minimizing heat loss by using an enzyme of black garlic. In this invention, after mixing black garlic and purified water, the enzyme is added, decomposed at 55 ° C. for 1 hour 30 minutes to 3 hours, and heat-treated at 95 ° C. for 10 minutes to inactivate the enzyme, then juiced, filtered, and concentrated again at low temperature. It is manufactured through a process, but three commercially available enzymes are used, and there is no example of an increase in active ingredient or extraction efficiency. In this method, the production cost increases due to the enzyme added by 0.5%, and there is a high possibility that the process will not be smooth due to the clogging of the filter during the extraction process after enzyme decomposition. .

등록특허 10-1105471호에서는 흑마늘 추출액을 제조함에 있어 매실농축액, 아가리쿠스버섯 균사체 추출액을 첨가함으로 기능성을 개선하고, 관능적 특성을 강화하는 방법을 제시하고 있다. 흑마늘, 흑삼, 흑대추를 첨가한 붕장어 음료 및 그 제조방법(등록특허 10-1181920) 특허에서는 흑마늘과 동일한 방식으로 흑삼을 제조한 후 붕장어에 첨가하여 추출함으로서 붕장어 음료를 제조함에 있어서 관능을 개선하고, 기능성을 강화하는 방법을 개시하고 있다. Patent Registration No. 10-1105471 proposes a method for improving functionality and enhancing sensory characteristics by adding plum concentrate and agaricus mushroom mycelium extract in the preparation of black garlic extract. In the patent for conger eel drink with black garlic, black ginseng, and black jujube added, and its manufacturing method (Registration Patent No. 10-11181920), black ginseng is prepared in the same manner as black garlic, and then added to conger eel and extracted to improve sensory in the manufacture of conger eel drink. , discloses a method for enhancing functionality.

이처럼 부재료를 혼합함으로써 기존의 흑마늘이 가지는 다양한 기능성을 강화하고, 흑마늘 특유의 맛을 개선하고자 하는 시도들이 이루어지고 있었으나 유효성분의 함량이 증가된 흑마늘 추출액과 이를 활용한 남성 건강증진용 조성물에 대한 연구 개발이 더욱 필요하다.In this way, attempts have been made to enhance the various functions of black garlic and improve the unique taste of black garlic by mixing sub-materials. More development is needed.

따라서, 본 발명은 통상적인 방법에 따라 적당량의 물을 가하여 가열함으로써 흑마늘 추출액을 얻을 수 있으나 본 발명에서 제시하는 조건에서 추출할 경우 흑마늘 추출물의 대표적인 유효성분인 총 페놀화합물과 SAC의 함량이 통상의 추출물에 비해 더 높은 추출물 및 이를 포함하는 흑마늘 음료를 제공하는 것을 목적으로 한다.Therefore, in the present invention, black garlic extract can be obtained by heating by adding an appropriate amount of water according to a conventional method. However, when extracted under the conditions presented in the present invention, the content of total phenolic compounds and SAC, which are representative active ingredients of black garlic extract, is conventional. An object of the present invention is to provide an extract higher than the extract and a black garlic beverage comprising the same.

또한, 본 발명은 흑마늘 추출액과 흑삼 등을 혼합함으로써 관능적 특성과 기능성이 강화된 남성 건강증진용 조성물을 제공하는 것을 목적으로 한다.In addition, an object of the present invention is to provide a composition for promoting men's health with enhanced sensory characteristics and functionality by mixing black garlic extract and black ginseng.

상기와 같은 과제를 해결하기 위한 본 발명의 일측면은, 흑마늘 무게 대비 3~4배의 물을 가하여 80~100℃에서 400~800분 동안 추출하여 얻어지는 흑마늘 추출물을 제공한다.One aspect of the present invention for solving the above problems provides a black garlic extract obtained by adding 3 to 4 times the weight of black garlic and extracting it at 80 to 100° C. for 400 to 800 minutes.

본 발명의 다른 측면은 상기 흑마늘 추출물을 포함하는 흑마늘 음료를 제공한다.Another aspect of the present invention provides a black garlic beverage comprising the black garlic extract.

본 발명의 또 다른 측면은 상기 흑마늘 추출물과 흑삼 추출물 또는 흑삼 분말을 포함하는 남성 건강증진용 조성물을 제공한다. 바람직하게는, 상기 흑마늘 추출물은 93~97중량%이고, 상기 흑삼 분말은 3~7중량%이며, 상기 흑마늘 추출물의 농도는 30 brix이다.Another aspect of the present invention provides a composition for promoting male health comprising the black garlic extract and black ginseng extract or black ginseng powder. Preferably, the black garlic extract is 93 to 97% by weight, the black ginseng powder is 3 to 7% by weight, and the concentration of the black garlic extract is 30 brix.

상기 남성 건강 증진용 조성물은 벌꿀을 더 포함할 수 있다. 바람직하게는, 상기 흑마늘 추출액은 78~82중량%, 상기 꿀은 12~17중량%, 상기 흑삼 분말은 1~5중량%이며, 상기 흑마늘 추출물의 농도는 30 brix이다.The composition for promoting male health may further include honey. Preferably, the black garlic extract is 78 to 82% by weight, the honey is 12 to 17% by weight, the black ginseng powder is 1 to 5% by weight, and the concentration of the black garlic extract is 30 brix.

본 발명에 따르면, 유효성분인 총 페놀화합물과 SAC의 함량이 높은 흑마늘 추출물 및 이를 포함하는 흑마늘 음료를 제공할 수 있다.According to the present invention, it is possible to provide a black garlic extract having a high content of total phenolic compounds and SAC as active ingredients, and a black garlic beverage containing the same.

또한, 본 발명에 따르면, 흑마늘 추출물과 흑삼 등을 혼합함으로써 유효성분의 함량과 항염증과 항산화활성의 증가 및 testosterone의 분비 증가와 발기력 유지와 관련된 인자의 증가를 유도함으로써 남성 건강 증진에도 도움이 되는 흑마늘 추출액을 포함하는 조성물을 제공할 수 있다.In addition, according to the present invention, by mixing black garlic extract and black ginseng, etc., the content of active ingredients, increase in anti-inflammatory and antioxidant activity, increase in secretion of testosterone, and increase in factors related to maintenance of erection are also helpful in promoting male health. A composition comprising black garlic extract may be provided.

도 1은 본 발명의 일실시예에 따른 농도별 추출물 5종의 RAW 264.7 세포에 대한 생존율 평가를 나타낸 그래프이다.
도 2는 본 발명의 일실시예에 따른 농도별 추출물 5종의 RAW 264.7 세포에 대한 NO 생성억제 활성 평가 결과를 나타낸 그래프이다.
도 3은 본 발명의 일실시예에 따른 농도별 추출물 5종의 RAW 264.7 세포에 대한 ROS 생성억제 활성 평가 결과를 나타낸 그래프이다.
도 4는 본 발명의 일실시예에 따른 농도별 추출물 5종의 Phosphodiesterase (PDE) 저해활성 평가 결과를 나타낸 그래프이다.
도 5는 본 발명의 일실시예에 따른 농도별 추출물 5종의 TM3 세포에 대한 생존율 평가 결과를 나타낸 그래프이다.
도 6은 본 발명의 일실시예에 따른 농도별 추출물 5종의 과산화수소에 처리에 대한 TM3 세포에서 생존효과를 나타낸 그래프이다.
도 7은 본 발명의 일실시예에 따른 농도별 추출물 5종을 처리한 TM3 세포에서 testosterone 분비량을 나타낸 그래프이다.
1 is a graph showing the evaluation of the viability of RAW 264.7 cells of 5 kinds of extracts by concentration according to an embodiment of the present invention.
Figure 2 is a graph showing the NO production inhibitory activity evaluation results for RAW 264.7 cells of 5 kinds of extracts by concentration according to an embodiment of the present invention.
3 is a graph showing the results of evaluation of ROS production inhibitory activity on RAW 264.7 cells of 5 kinds of extracts by concentration according to an embodiment of the present invention.
4 is a graph showing the evaluation results of Phosphodiesterase (PDE) inhibitory activity of 5 extracts by concentration according to an embodiment of the present invention.
5 is a graph showing the evaluation results of the viability of 5 types of TM3 cells of the extract according to the concentration according to an embodiment of the present invention.
6 is a graph showing the survival effect in TM3 cells for the treatment with 5 kinds of hydrogen peroxide extracts by concentration according to an embodiment of the present invention.
7 is a graph showing the amount of testosterone secretion in TM3 cells treated with 5 types of extracts by concentration according to an embodiment of the present invention.

본 발명의 일측면은, 흑마늘 무게 대비 3~4배의 물을 가하여 80~100℃에서 400~800분 동안 추출하여 얻어지는 흑마늘 추출물을 제공한다.One aspect of the present invention provides a black garlic extract obtained by adding 3 to 4 times the weight of black garlic and extracting it at 80 to 100° C. for 400 to 800 minutes.

본 발명의 다른 측면은 상기 흑마늘 추출물을 포함하는 흑마늘 음료를 제공한다.Another aspect of the present invention provides a black garlic beverage comprising the black garlic extract.

본 발명의 또 다른 측면은 상기 흑마늘 추출물과 흑삼 추출물 또는 흑삼 분말을 포함하는 남성 건강증진용 조성물을 제공한다. 바람직하게는, 상기 흑마늘 추출물은 93~97중량%이고, 상기 흑삼 분말은 3~7중량%이며, 상기 흑마늘 추출물의 농도는 30 brix이다.Another aspect of the present invention provides a composition for promoting male health comprising the black garlic extract and black ginseng extract or black ginseng powder. Preferably, the black garlic extract is 93 to 97% by weight, the black ginseng powder is 3 to 7% by weight, and the concentration of the black garlic extract is 30 brix.

상기 남성 건강 증진용 조성물은 벌꿀을 더 포함할 수 있다. 바람직하게는, 상기 흑마늘 추출액은 78~82중량%, 상기 꿀은 12~17중량%, 상기 흑삼 분말은 1~5중량%이며, 상기 흑마늘 추출물의 농도는 30 brix이다.The composition for promoting male health may further include honey. Preferably, the black garlic extract is 78 to 82% by weight, the honey is 12 to 17% by weight, the black ginseng powder is 1 to 5% by weight, and the concentration of the black garlic extract is 30 brix.

이하, 본 발명의 실시예를 들어 본 발명에 대해 보다 상세히 설명한다. 하기 실시예는 본 발명을 설명하기 위한 예시에 불과한 것이며, 본 발명의 권리범위가 이러한 실시예로 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to examples of the present invention. The following examples are merely examples for explaining the present invention, and the scope of the present invention is not limited to these examples.

[[ 실시예Example 1] 중심합성계획에 의한 1] According to the central synthesis plan 흑마늘black garlic 추출조건의 최적화 Optimization of extraction conditions

흑마늘의 추출조건을 최적화하기 위하여 통상적인 흑마늘의 추출조건에 사용되는 80~93℃에서 360~668분 동안 추출을 실시하였다. 이때, 가수량은 선행연구결과에서 온도나 시간에 비해서 추출물의 성상에 미치는 영향이 상대적으로 낮음이 확인되었다. 따라서, 가수량은 통상적으로 추출시 적용되는 3~4배수의 범위로 실시되었다. 추출조건의 최적화를 위한 실험조건은 하기 표 1과 같다. 여러 조건의 시료를 제조함에 있어 통계적인 방법인 중심합성계획법에 의한 반응표면분석법을 적용하였다. In order to optimize the extraction conditions of black garlic, extraction was carried out for 360 to 668 minutes at 80-93° C., which is used for conventional extraction conditions of black garlic. At this time, it was confirmed that the amount of water had a relatively low effect on the properties of the extract compared to temperature or time in the results of previous studies. Therefore, the amount of water was usually carried out in the range of 3 to 4 times applied during extraction. Experimental conditions for optimization of extraction conditions are shown in Table 1 below. In the preparation of samples under various conditions, a response surface analysis method based on the central synthesis programming method, which is a statistical method, was applied.

[표 1][Table 1]

Figure 112019087224074-pat00001
Figure 112019087224074-pat00001

(1) 중심합성계획에 의한 흑마늘 추출물의 이화학적 분석 (1) Physicochemical analysis of black garlic extract by central synthesis scheme

표 1의 조건에 따라 온도와 시간 조건을 달리한 11종의 시료를 각각 제조한 후 여과지로 여과한 추출액을 시료로 사용하였다. 추출액은 자동굴절 당도계를 이용하여 고형분함량은 측정하여 brix로 표시하였다. 추출액의 총 페놀 화합물의 함량은 페놀성 물질이 phosphomolybdic acid와 반응하여 청색을 나타내는 원리인 Foiln-Denis 방법을 이용하여 정량하였다. 시료액 1 mL에 Foline- Ciocalteau 시약(Sigma-Aldrich Co., St. Louis, MO, USA) 및 10% NaCO3 용액(Daejung, Siheung, Gyenggi, Korea)을 각 1 mL씩 차례로 가한 다음 실온에서 1시간 정치한 후 분광광도계(Libra S 35, Biochrom, Cambridge, England)로 760 nm에서 흡광도를 측정하였다. 표준물질로 gallic acid(Sigma-Aldrich Co., St, Louis, MO, USA)를 사용하여 시료와 동일한 방법으로 분석하여 얻은 검량선으로부터 총 페놀 화합물의 함량을 계산하였다. According to the conditions in Table 1, 11 types of samples with different temperature and time conditions were prepared, respectively, and an extract filtered with a filter paper was used as a sample. The solid content of the extract was measured using an automatic refraction saccharometer and expressed as brix. The content of total phenolic compounds in the extract was quantified using the Foiln-Denis method, which is the principle that a phenolic substance reacts with phosphomolybdic acid to produce a blue color. To 1 mL of the sample solution, 1 mL each of Foline-Ciocalteau reagent (Sigma-Aldrich Co., St. Louis, MO, USA) and 10% NaCO 3 solution (Daejung, Siheung, Gyenggi, Korea) were sequentially added, followed by 1 mL at room temperature. After standing for time, absorbance was measured at 760 nm with a spectrophotometer (Libra S 35, Biochrom, Cambridge, England). Using gallic acid (Sigma-Aldrich Co., St, Louis, MO, USA) as a standard material, the content of total phenolic compounds was calculated from the calibration curve obtained by analyzing in the same manner as the sample.

S-allyl-cysteine(SAC) 함량은 시료를 0.22 μm syringe filter로 여과하여 HPLC-PDA-MS/MS(TSQ Quantum LC-MS/MS, Thermo scientific, Waltham, MA, USA)로 분석하였다. 분석용 칼럼은 Agilent Zorbax SB-C18(4.6×250 mm, 5 μm)를 사용하였고, 이동상 용매는 positive mode에서 이동상 A(0.1% formic acid containing water)와 B(0.1% formic acid containing acetonitrile)을 시간에 따라 혼합비율을 달리하면서 분석하였다. 이동상의 속도는 0.7 mL/min, 시료 주입량은 10 μL, scan type은 SRM mode로 하여 분석을 실시하였다. 추출액 중의 SAC 함량은 농도별 표준물질을 시료와 동일한 조건에서 분석하여 함량을 정량하였다. 분석 결과는 하기 표 2와 같다.The S-allyl-cysteine (SAC) content was analyzed by filtration with a 0.22 μm syringe filter and HPLC-PDA-MS/MS (TSQ Quantum LC-MS/MS, Thermo scientific, Waltham, MA, USA). Agilent Zorbax SB-C 18 (4.6×250 mm, 5 μm) was used as the analytical column, and mobile phase A (0.1% formic acid containing water) and B (0.1% formic acid containing acetonitrile) were used as the mobile phase solvent in positive mode. The analysis was performed while varying the mixing ratio according to time. The speed of the mobile phase was 0.7 mL/min, the sample injection amount was 10 μL, and the scan type was SRM mode. The content of SAC in the extract was quantified by analyzing the standard material for each concentration under the same conditions as the sample. The analysis results are shown in Table 2 below.

[표 2][Table 2]

Figure 112019087224074-pat00002
Figure 112019087224074-pat00002

상기 표 2에 나타낸 바와 같이 고형분 함량은 9.3~14.70 brix의 범위였고 총 페놀화합물의 함량은 80.89~125.60 mg/100g 이고, 흑마늘 추출액의 주요 유효성분 중 하나인 SAC 함량은 10.91~30.53 mg/100g의 범위였다. 분석된 이화학적 특성들은 온도가 높을수록, 추출시간이 길수록 더 높았다. As shown in Table 2, the solid content was in the range of 9.3 to 14.70 brix, the total phenolic compound content was 80.89 to 125.60 mg/100g, and the SAC content, one of the main active ingredients of the black garlic extract, was 10.91 to 30.53 mg/100g. was the range. The analyzed physicochemical properties were higher with higher temperature and longer extraction time.

(2) 흑마늘 추출조건 및 분석결과에 기반한 다항식(2) Polynomial based on black garlic extraction conditions and analysis results

상기 표 2의 이화학적 분석 결과로부터 추출조건에 해당하는 변수인 X 1 (추출온도, ℃), X 2 (추출시간, 분)와 분석 결과인 Y 1 (brix), Y 2 (total phenol), Y 3 (SAC) 간의 상관성에 기반한 반응식은 표 3과 같다.From the physicochemical analysis results in Table 2 above, the variables corresponding to the extraction conditions, X 1 (extraction temperature, ℃), X 2 (extraction time, minutes), and the analysis results, Y 1 (brix), Y 2 (total phenol), A reaction equation based on the correlation between Y 3 (SAC) is shown in Table 3.

[표 3][Table 3]

Figure 112019087224074-pat00003
Figure 112019087224074-pat00003

상기 표 3으로부터 고형분함량, 총 페놀화합물 및 SAC 모두 R 2 값이 80% 이상으로 주어진 추출조건들과 결과 값 사이에 상관성이 있음을 알 수 있다. From Table 3 above, it can be seen that there is a correlation between the extraction conditions and the result value given that the R 2 value is 80% or more for all of the solid content, total phenolic compounds, and SAC.

(3) 시판 흑마늘 분석 결과 및 최적 추출 조건에서 예상치 (3) Results of analysis of commercially available black garlic and expected under optimal extraction conditions

이상의 분석 결과들은 시판되고 있는 흑마늘 추출액과의 비교를 통해 흑마늘 추출액 제조를 위한 최적 조건을 확인하였다. 시판되고 있는 흑마늘 추출액 6종을 본 추출액과 동일한 방법 및 조건에서 분석하여 평균값을 얻었으며, 이와 본 발명에서 개발하고자 하는 흑마늘 추출액의 제조 조건을 최적화한 결과는 하기 표 4와 같다. The above analysis results confirmed the optimal conditions for preparing the black garlic extract through comparison with the commercially available black garlic extract. The average value was obtained by analyzing 6 commercially available black garlic extracts under the same method and conditions as those of this extract, and the results of optimizing the production conditions for the black garlic extract to be developed in the present invention are shown in Table 4 below.

[표 4][Table 4]

Figure 112019087224074-pat00004
Figure 112019087224074-pat00004

상기 표 4에서 추출조건 1은 86.6℃에서 720분간 추출할 경우 얻을 수 있는 값이며, 추출조건 2는 92.7℃에서 412분간 추출하여 얻을 수 있는 값이다. 두 추출조건 모두에서 시판 제품 대비 20% 씩 SAC 함량이 증가된 추출물을 얻을 수 있으며, 시판 제품과 동일한 정도의 농도를 가지되 총 페놀화합물의 함량을 높이고자 한다면 추출조건 1에 따라 추출할 수 있다. In Table 4, extraction condition 1 is a value obtained when extraction is performed at 86.6° C. for 720 minutes, and extraction condition 2 is a value obtained by extraction at 92.7° C. for 412 minutes. Under both extraction conditions, an extract with an increased SAC content by 20% compared to the commercial product can be obtained. .

또한, 총 페놀화합물이 함량은 시판 제품과 동일하게 유지하되, 고형분의 함량을 시판 제품 대비 약 1.7배 더 높이고자 한다면 추출조건 2에 따라 추출할 수 있다. In addition, if the total phenolic compound content is maintained the same as that of the commercial product, but the solid content is to be increased by about 1.7 times compared to the commercial product, it can be extracted according to extraction condition 2.

또한, 두 조건은 상대적으로 추출 온도가 87℃ 정도로 낮은 경우는 시간을 길게 유지하여야 하되, 그 최적 시간을 확인할 수 있으며, 온도를 93℃ 정도로 높일 경우에는 약 7시간 정도의 추출로 원하는 성분들을 모두 용출할 수 있음을 알 수 있다. In addition, in both conditions, when the extraction temperature is relatively low as low as 87 ℃, the time should be maintained long, but the optimal time can be confirmed. It can be seen that it can be eluted.

이상과 같은 조건에서 추출한 액은 시판되고 있는 흑마늘 추출액과 농도가 유사하거나 진하기 때문에 추출액만으로도 음료로 제조 가능하다. 또한, 다른 제형으로 개발하기 위해서는 이를 농축하여 농도를 높여서 사용할 수 있다. The liquid extracted under the above conditions is similar to or thicker than the commercially available black garlic extract, so it can be prepared as a beverage only with the extract. In addition, in order to develop into another formulation, it can be concentrated and used to increase the concentration.

[[ 실시예Example 2] 2] 흑마늘black garlic 추출액을 기반으로 한 조성물 제조 Preparation of a composition based on the extract

흑마늘 추출액의 기능성과 관능적 특성을 강화하기 위하여 부재료들이 첨가된 조성물을 제조하고, 이를 음료로 활용하기 위한 배합비를 설정하였다. 다양한 부재료를 첨가하여 기능성을 강화할 수 있으나 본 발명에서는 다른 부재료를 추가로 첨가할 수 있는 베이스가 되는 조성물을 제안함으로써, 추가적인 제품들의 개발 가능성을 제공하고자 하였다. In order to enhance the functional and sensory properties of black garlic extract, a composition with additional ingredients was prepared, and a blending ratio was set for using it as a beverage. Functionality can be enhanced by adding various sub-materials, but in the present invention, by proposing a composition serving as a base to which other sub-materials can be additionally added, it was intended to provide the possibility of developing additional products.

베이스가 되는 조성물의 혼합 부재료로는 흑삼과 꿀을 사용하였다. 흑삼은 추출액으로 사용하여도 무방하며 건조된 것을 분말화하여 사용하여도 무방하다. 본 발명에서는 흑마늘 추출액과 혼합하여 고농축 스틱음료를 제조하는 데 맞추고자 분말을 사용하였다. 고형분 함량 30 brix의 흑마늘 추출 농축액과 흑삼 분말, 꿀을 혼합한 조성물 베이스는 표 5와 같다. 배합 1은 흑마늘 추출액의 효과를 확인하기 위한 대조군이며, 배합 2는 본 발명에서 제안하고자 하는 조성물의 기본 배합비 중 하나이며, 배합 3은 흑삼의 첨가 효과를 확인하기 위한 대조군 중의 하나이다. 하기 표에서 비율은 중량%이다.Black ginseng and honey were used as mixing materials for the base composition. Black ginseng may be used as an extract, or dried and powdered. In the present invention, powder was used to mix with black garlic extract to prepare a highly concentrated stick drink. Table 5 shows the composition base, which is a mixture of black garlic extract concentrate with a solid content of 30 brix, black ginseng powder, and honey. Formulation 1 is a control to confirm the effect of black garlic extract, Formulation 2 is one of the basic compounding ratios of the composition to be proposed in the present invention, and Formulation 3 is one of the controls to confirm the effect of adding black ginseng. In the table below, the proportions are % by weight.

[표 5][Table 5]

Figure 112019087224074-pat00005
Figure 112019087224074-pat00005

(1) 흑마늘 추출액과 흑삼분말 혼합 조성물의 총 페놀화합물 함량 및 콜레스테롤 흡착활성(1) Total phenolic compound content and cholesterol adsorption activity of black garlic extract and black ginseng powder mixture composition

총 페놀화합물의 함량은 조성물 1 mL를 취하여 상기 총 페놀화합물 함량 분석 방법과 동일한 방법에 따라 분석하였다. 콜레스테롤 흡착활성은 kit시약(AM 202-k, AsanPharm., Seoul, Korea)으로 측정하였다. 시료액 1 mL에 콜레스테롤(300 mg/dL) 50 μL를 가하여 25℃에서 20분간 반응시킨 후 0.1 M hexadecyl-trimethylammonium bromide (Sigma Co., St Louis, MO, USA) 50 μL를 첨가하여 25,000×g 에서 15분간 원심분리시켰다. 상층액 200 μL를 취하여 효소액 1.5 mL을 가해 혼합한 후 37℃에서 5분간 반응시킨 다음 500 nm에서 흡광도를 측정하였으며, 시료 무첨가구에 대한 시료 첨가군의 흡광도 비로써 콜레스테롤 흡착활성 (%)을 나타내었다. The total phenolic compound content was analyzed according to the same method as the total phenolic compound content analysis method by taking 1 mL of the composition. Cholesterol adsorption activity was measured with a kit reagent (AM 202-k, Asan Pharm., Seoul, Korea). Add 50 µL of cholesterol (300 mg/dL) to 1 mL of the sample solution, react at 25°C for 20 minutes, and then add 50 µL of 0.1 M hexadecyl-trimethylammonium bromide (Sigma Co., St Louis, MO, USA) to 25,000×g. was centrifuged for 15 min. After taking 200 μL of the supernatant, adding 1.5 mL of the enzyme solution, mixing, and reacting at 37°C for 5 minutes, the absorbance was measured at 500 nm. it was

총 페놀화합물과 콜레스테롤 흡착활성을 분석한 결과는 하기 표 6과 같다. The results of analysis of total phenolic compounds and cholesterol adsorption activity are shown in Table 6 below.

[표 6][Table 6]

Figure 112019087224074-pat00006
Figure 112019087224074-pat00006

상기 표 6으로부터, 흑마늘 추출액이 첨가되지 않는 배합 1 시료의 총 페놀화합물 함량은 51.18 μ흑삼이 첨가되지 않은 배합 3은 50.26 μ으로 큰 차이를 나타내지 않은 반면 두 시료가 혼합된 배합 2는 139.33 μ으로 배합 1과 2에 비해 약 2.7배가 상승하였다. 두 시료가 혼합되면서 그 함량에 시너지 효과를 보인 것은 미량으로 존재하던 페놀화합물들이 서로 혼합되어 그 양이 증가함에 따라 정량이 가능해짐으로써 더 함량이 증가된 결과를 나타낸 것으로 생각된다.From Table 6, the total phenolic compound content of the formulation 1 sample without the addition of black garlic extract was 51.18 μ, the formulation 3 without the addition of black ginseng was 50.26 μ, which did not show a significant difference, whereas the formulation 2 in which the two samples were mixed was 139.33 μ. It increased about 2.7 times compared to formulations 1 and 2. The fact that the two samples showed a synergistic effect on the content is thought to indicate that the phenolic compounds present in trace amounts were mixed with each other and quantification became possible as the amount increased, resulting in an increased content.

콜레스테롤 흡착활성은 배합 1이 24.75%, 배합 3은 22.9%인 반면 배합 2은 52.62%로 배합 1과 2에 비해 약 2.1 배 이상이 증가하에 총 페놀화합물의 분석 결과와 일치하는 경향이었다.Cholesterol adsorption activity was 24.75% for Formulation 1 and 22.9% for Formulation 3, whereas Formulation 2 was 52.62%, which was approximately 2.1 times higher than that of Formulations 1 and 2, which was consistent with the analysis results of total phenolic compounds.

(2) 흑마늘 추출액과 흑삼분말 혼합 조성물의 ABTS 및 DPPH 라디칼 항산화 활성(2) ABTS and DPPH radical antioxidant activity of black garlic extract and black ginseng powder mixture composition

항산화 활성 중 DPPH(1,1-Diphenyl-2-picrylhydrazyl) 라디칼 소거활성은 DPPH에 대한 전자공여 활성으로 나타낸 것으로 시료액과 DPPH 용액(5 mg/100 mL methanol)을 동량으로 혼합한 다음 실온에서 20분간 반응시킨 후 분광광도계를 이용하여 525 nm에서 흡광도를 측정하였다.Among the antioxidant activity, DPPH (1,1-Diphenyl-2-picrylhydrazyl) radical scavenging activity is expressed as electron donating activity for DPPH. After mixing the sample solution and DPPH solution (5 mg/100 mL methanol) in equal amounts, the After reacting for a minute, absorbance was measured at 525 nm using a spectrophotometer.

ABTS(2,2-azinobis-(3-ethylbenzo- thiazoline-6-sulphonate) 라디칼 소거활성은 7 mM의 ABTS 용액에 potassium persulfate(Sigma-Aldrich Co., St. Louis, MO, USA)를 2.4 mM이 되도록 용해시킨 다음 암실에서 12~16시간 동안 반응시킨 후 415 nm에서 흡광도가 1.5가 되도록 증류수로 조정한 ABTS 용액을 사용하였다. ABTS 용액 150 μL에 시료액 50 μL를 혼합하고 실온에서 반응시킨 다음 분광광도계를 이용하여 415 nm에서 흡광도를 측정하였다. The radical scavenging activity of ABTS (2,2-azinobis-(3-ethylbenzo-thiazoline-6-sulphonate) was determined by adding potassium persulfate (Sigma-Aldrich Co., St. Louis, MO, USA) to 7 mM ABTS solution at 2.4 mM. After dissolving as much as possible, and reacting in the dark for 12 to 16 hours, an ABTS solution adjusted with distilled water so that the absorbance at 415 nm becomes 1.5 was mixed 50 μL of the sample solution was mixed with 150 μL of ABTS solution, reacted at room temperature, followed by spectroscopy Absorbance was measured at 415 nm using a photometer.

DPPH 및 ABTS 라디칼 소거활성은 시료 무첨가구에 대한 시료첨가구의 흡광도비로 계산하여 %로 나타내었으며 그 결과는 하기 표 7과 같다. The DPPH and ABTS radical scavenging activities were calculated as the absorbance ratio of the sample-added group to the non-sample-added group and expressed in %, and the results are shown in Table 7 below.

[표 7][Table 7]

Figure 112019087224074-pat00007
Figure 112019087224074-pat00007

상기 표 7을 참조해보면, 배합 비율에 따른 항산화 활성은 배합비율에 따라 활성에 차이가 있었는데, 흑마늘과 흑삼만 첨가한 배합 1, 3에 비해 혼합한 배합 2의 활성이 더 높았다. 100 mg/g의 농도에서 배합 1의 ABTS 라디칼소거 활성이 54.02%인데 비해 두 시료가 혼합된 배합 2에서는 97.11%로 약 2배 이상 증가하였다. 또한 흑삼만 첨가된 배합 3은 53.76%로 두 시료가 혼합된 시료보다 낮았다.Referring to Table 7, the antioxidant activity according to the blending ratio was different in activity depending on the blending ratio, and the activity of blend 2 was higher than blends 1 and 3 in which only black garlic and black ginseng were added. At a concentration of 100 mg/g, the ABTS radical scavenging activity of Formulation 1 was 54.02%, whereas in Formulation 2, in which the two samples were mixed, it increased more than twice to 97.11%. In addition, formulation 3 containing only black ginseng was 53.76% lower than the sample in which the two samples were mixed.

이상의 결과로부터 흑마늘 추출액이나 흑삼을 단독 사용할 경우에 비해서 두 성분이 혼합됨으로 인해 유효성분인 페놀화합물이나 SAC의 함량이 증가하고, 이로 인해 항산화 활성이 증가함이 확인되었다. 대부분의 결과에서 두 시료에서 유효성분의 함량이나 활성의 차이가 클 경우 두 성분을 혼합하면 유효성분의 함량이 낮고, 활성이 더 낮은 시료의 활성은 증가되지만 유효성분의 함량이 높고, 활성이 더 우수한 시료의 활성은 오히려 더 낮아지는 효과를 보이면서 유효성분의 함량이나 활성이 평균값에 이르게 된다.From the above results, compared to the case of using black garlic extract or black ginseng alone, it was confirmed that the content of active ingredients such as phenolic compounds or SAC increased due to the mixing of the two components, which resulted in increased antioxidant activity. In most of the results, if the content or activity of the two samples is large, mixing the two components increases the activity of the sample with a lower content and lower activity, but increases the content or activity of the active ingredient. The activity of the excellent sample is rather lowered, and the content or activity of the active ingredient reaches an average value.

하지만, 본 발명에서는 활성이 크게 차이가 나지 않는 성분을 혼합함으로써 시너지 효과를 발휘하여 두 성분의 유효성분이나 활성이 더 증가하는 긍정적인 결과를 나타내었다.However, in the present invention, a synergistic effect was exerted by mixing ingredients with no significant difference in activity, thereby showing a positive result in which the active ingredients or activities of the two components were further increased.

[[ 실시예Example 3] 3] 흑마늘black garlic 추출액을 기반으로 하는 조성물의 세포 수준에서 활성 검증을 위한 시료의 제조 Preparation of samples for verification of activity at the cellular level of compositions based on extracts

세포수준에서 흑마늘과 흑삼 및 이들의 비율별 조성물의 생리활성을 검증하고자 흑마늘 추출물과 흑마늘과 동일 조건에서 추출한 흑삼 추출액을 각각 동결건조한 후 분말화하였다. 동결건조된 흑마늘 추출 분말(B. garlic)과 흑삼 추출분말(B. ginseng)을 무게 비에 따라 각각 97:3(Mix 1), 95:5(Mix 2), 93:7(Mix 3)의 비율로 혼합한 조성물 3종을 시료로 제조하여 정제수를 가해 일정한 농도로 만들어서 세포실험에 이용하였다.To verify the physiological activity of black garlic and black ginseng and their composition at the cellular level, black garlic extract and black ginseng extract extracted under the same conditions as black garlic were each freeze-dried and then powdered. According to the weight ratio of freeze-dried black garlic extract powder (B. garlic) and black ginseng extract powder (B. ginseng), respectively, 97:3 (Mix 1), 95:5 (Mix 2), 93:7 (Mix 3) Three types of compositions mixed in a ratio were prepared as samples, and purified water was added to make a constant concentration and used for cell experiments.

(1) RAW 264.7 대식세포에 대한 활성 검증을 위한 세포독성 평가 (1) Cytotoxicity evaluation for verification of activity against RAW 264.7 macrophages

실험에 사용된 RAW 264.7 세포는 한국세포주은행(KCLB, Korea)에서 분양받았으며, 세포 배양을 위해 10% fetal bovine serum(FBS, Hyclone, Loran, UT, USA)과 1% penicillin-streptomycin을 포함하는 DMEM(dulbecco's modied eagle's medium) 배지를 사용하였다. The RAW 264.7 cells used in the experiment were purchased from the Korea Cell Line Bank (KCLB, Korea), and for cell culture, DMEM containing 10% fetal bovine serum (FBS, Hyclone, Loran, UT, USA) and 1% penicillin-streptomycin (dulbecco's modied eagle's medium) medium was used.

실험에 유효한 시료의 농도 설정을 위하여 세포에 대한 독성을 먼저 확인하였다. 세포독성 평가를 위하여 RAW 264.7 세포는 CO2 incubator(37℃, 5% CO2)에서 배양하였으며 추출물의 세포에 대한 독성 측정은 3-(4,5-dimethylthiazole-2-yl)- 2,5-diphenyltetrazolium bromide(MTT, Gibco, Waltham, MA, USA) 환원방법을 이용하여 측정하였다. 세포를 96 well-plate에 well당 5×104개가 되도록 분주하고 24시간 부착시킨 후, 추출물들을 각기 일정한 농도로 희석하여 세포에 처리한 다음 30분 후 1 μg/mL 농도의 lipopolysaccharide(LPS, Sigma-Aldrich Co., St. Louis, MO, USA)를 처리하여 24시간 동안 배양하였다. 이후 시료를 포함하는 배지를 제거한 후 serum-free 배지와 5 mg/mL 농도의 MTT 용액을 첨가하여 37℃에서 2시간 더 배양한 다음 DMSO를 분주하여 sonication하고 10분간 교반한 뒤 570 nm에서 흡광도를 측정해 세포생존율을 구하였다. 세포생존율은 무처리군에 대한 백분율로 나타내었다.In order to set the concentration of the sample effective for the experiment, the toxicity to the cells was first confirmed. For cytotoxicity evaluation, RAW 264.7 cells were cultured in a CO 2 incubator (37℃, 5% CO 2 ), and the cell toxicity of the extract was measured with 3-(4,5-dimethylthiazole-2-yl)-2,5- Diphenyltetrazolium bromide (MTT, Gibco, Waltham, MA, USA) was measured using the reduction method. Cells were aliquoted to 5×10 4 cells per well in a 96 well-plate and adhered for 24 hours. The extracts were diluted to a constant concentration and treated with lipopolysaccharide (LPS, Sigma) at a concentration of 1 μg/mL after 30 minutes. -Aldrich Co., St. Louis, MO, USA) was treated and cultured for 24 hours. After removing the medium containing the sample, serum-free medium and MTT solution at a concentration of 5 mg/mL were added, and incubated at 37°C for 2 hours, then DMSO was dispensed, sonicated, and the absorbance was measured at 570 nm after stirring for 10 minutes. was measured to determine the cell viability. Cell viability was expressed as a percentage of the untreated group.

RAW 264.7 세포에 흑마늘, 흑삼 및 3종 혼합 추출물을 각각 농도별(0, 100, 200, 400 및 800 μg/mL)로 24시간 동안 처리한 결과(도 1), 800 μg/mL 농도 범위까지 모든 시료가 대조군 대비 세포 독성이 유발되지 않는 것으로 확인되었다. 따라서 실험을 위한 최고 시료의 처리 농도는 800 μg/mL 이하로 설정하였다. As a result of processing RAW 264.7 cells with black garlic, black ginseng, and three types of mixed extracts at each concentration (0, 100, 200, 400 and 800 μg/mL) for 24 hours (Fig. 1), all extracts up to 800 μg/mL concentration range It was confirmed that the sample did not induce cytotoxicity compared to the control. Therefore, the treatment concentration of the highest sample for the experiment was set to 800 μg/mL or less.

농도별 추출물 5종의 RAW 264.7 세포에 대한 생존율 평가를 나타낸 그래프는 도 1과 같다. 도 1에서, 모든 시료 값은 동일한 조건으로 3회 반복실험을 한 결과에 대한 평균±편차 값으로 표시하였다.A graph showing the evaluation of the viability of RAW 264.7 cells of 5 extracts by concentration is shown in FIG. 1 . In FIG. 1, all sample values were expressed as mean±deviation values for the results of three repeated experiments under the same conditions.

(2) RAW 264.7 대식세포를 이용한 항염증 활성 평가 (2) Evaluation of anti-inflammatory activity using RAW 264.7 macrophages

항염증 활성은 RAW 264.7 대식세포에서 nitric oxide(NO) 생성억제율을 통해 평가하였다. 마우스 대식세포주인 RAW 264.7세포를 5×105 cell/well의 농도로 24-well plate에 분주하여 24시간 배양한 후 각각의 추출물을 농도별로 처리하였다. 이것을 30분 배양한 후에 LPS(1 μg/mL)를 처리하여 20시간 또는 24시간 배양한 후 세포 상등액을 회수하였다. 회수한 세포 배양 상등액을 원심분리(1,000 rpm, 10min, 4℃) 한 다음, 50 μL를 취해 sulfanilamide solution 50 μL와 혼합하여 5분간 빛을 차단하고 반응시킨 후 NED solution 50 μL와 혼합하여 상온에서 10분간 반응시켜, ELISA reader(Epoch, Bioteck, Winooski, VT, Germany)를 이용하여 540 nm에서 흡광도를 측정하였고, LPS 단독처리세포군에 대한 상대적인 생성율로 나타내었다.Anti-inflammatory activity was evaluated through the inhibition rate of nitric oxide (NO) production in RAW 264.7 macrophages. RAW 264.7 cells, a mouse macrophage cell line, were dispensed in a 24-well plate at a concentration of 5×10 5 cells/well and cultured for 24 hours, and then each extract was treated by concentration. After incubating this for 30 minutes, it was treated with LPS (1 μg/mL) and cultured for 20 hours or 24 hours, and then the cell supernatant was recovered. After centrifugation (1,000 rpm, 10min, 4℃) of the recovered cell culture supernatant, take 50 μL, mix with 50 μL of sulfanilamide solution, block light for 5 minutes, react, and mix with 50 μL of NED solution at room temperature for 10 minutes. After reacting for minutes, absorbance was measured at 540 nm using an ELISA reader (Epoch, Bioteck, Winooski, VT, Germany), and it was expressed as a relative production rate for the LPS-only treated cell group.

LPS를 처리한 RAW 264.7 세포를 대상으로 흑마늘, 흑삼 및 3종 혼합 추출물의 nitric oxide(NO) 생성 억제활성을 측정한 결과는 도 2와 같다. LPS를 처리한 RAW 264.7 세포는 대조군보다 NO의 생성이 증가하였으며, 5가지 추출물을 각각 처리하였을 때 100~800 μg/mL 농도에서 시료의 처리농도가 증가함에 따라 NO 생성량은 유의하게 감소하였다(p<0.05). 추출물별 NO 생성 억제효과는 800 μg/mL 농도에서 흑삼 추출물이 가장 높고 나머지 추출물들은 서로 유사한 범위였다. The results of measuring the nitric oxide (NO) production inhibitory activity of black garlic, black ginseng and three types of mixed extracts in RAW 264.7 cells treated with LPS are shown in FIG. 2 . RAW 264.7 cells treated with LPS increased NO production compared to the control group, and when each of the five extracts was treated, the amount of NO production significantly decreased as the concentration of the sample increased at a concentration of 100 to 800 μg/mL (p <0.05). The NO production inhibitory effect of each extract was highest in the black ginseng extract at the concentration of 800 μg/mL, and the remaining extracts were in a similar range.

농도별 추출물 5종의 RAW 264.7 세포에 대한 NO 생성억제 활성 평가에 대한 그래프는 도 2와 같다. 모든 시료 값은 동일한 조건으로 3회 반복실험을 한 결과에 대한 평균±편차 값으로 표시하였다. (*, p<0.05; **, p<0.01; ***, p<0.001). A graph for the evaluation of NO production inhibitory activity against RAW 264.7 cells of 5 types of extracts by concentration is shown in FIG. 2 . All sample values were expressed as mean±deviation values for the results of three repeated experiments under the same conditions. (*, p<0.05; **, p<0.01; ***, p<0.001).

NO(nitric oxide)는 주로 LPS 또는 TNF-α 등의 염증 유발물질에 의해 자극된 세포가 염증을 유발할 때 분비하는 염증반응 매개물질로 알려져 있다. 이와 같은 NO의 생성은 L-arginine의 guanidino nitrogen이 산화에 의해 L-citrulline으로 변화하는 L-argininenitric oxide 경로를 통하여 생성되는데, 대식세포, 호중구 등의 면역세포와 섬유모세포, 혈관의 평활근, 및 기도 상피세포에 있는 inducible nitric oxide synthase(iNOS) 효소의 활성에 의해 NO가 다량 생성되며 염증 반응을 증가시킨다고 알려져 있다. NO (nitric oxide) is known as an inflammatory response mediator secreted when cells stimulated by inflammatory substances such as LPS or TNF-α mainly induce inflammation. Such NO is produced through the L-argininenitric oxide pathway in which the guanidino nitrogen of L-arginine is converted to L-citrulline by oxidation. It is known that a large amount of NO is produced by the activity of the inducible nitric oxide synthase (iNOS) enzyme in epithelial cells and increases the inflammatory response.

(3) RAW 264.7 대식세포를 이용한 항산화 활성 평가(3) Evaluation of antioxidant activity using RAW 264.7 macrophages

추출물의 intracellular reactive oxygen species(ROS) 측정을 통해 세포수준에서 항산화 활성을 평가하였다. 96 well black plate에 5×104 cell/well의 RAW 264.7 cell을 분주하여 배양 한 후 serum free DMEM 배지로 교환하였다. 다시 세포를 24시간 배양한 후 시료를 농도별로 처리하여 37℃, 5% CO2 조건에서 24시간 배양하였다. PBS(pH 7.4)로 3회 세척한 후 1X dichloro-dihydro-fluorescein diacetate(DCFH-DA)를 배지에 100 μL 첨가하여 37℃, 5% CO2에서 1시간 배양한 후 또 다시 PBS로 3회 씻어냈다. Lysis buffer 100 μL를 첨가하여 혼합한 후 fluorescence microplate reader를 이용하여 excitation 485 nm, emisssion 535 nm에서 형광을 측정하여 LPS 단독 처리군에 대한 상대적인 ROS 생성 억제율을 비교하여 나타내었다.Antioxidant activity was evaluated at the cellular level by measuring the intracellular reactive oxygen species (ROS) of the extract. 5×10 4 cells/well of RAW 264.7 cells were aliquoted in a 96-well black plate and cultured, followed by exchange with serum-free DMEM medium. After culturing the cells for 24 hours, the samples were treated by concentration and cultured for 24 hours at 37° C., 5% CO 2 condition. After washing 3 times with PBS (pH 7.4), add 100 μL of 1X dichloro-dihydro-fluorescein diacetate (DCFH-DA) to the medium, incubate at 37°C, 5% CO 2 for 1 hour, and then wash 3 times with PBS again paid After adding and mixing 100 μL of lysis buffer, fluorescence was measured at excitation 485 nm and emisssion 535 nm using a fluorescence microplate reader, and the relative inhibition of ROS generation compared to the LPS-only treatment group was shown.

5종 추출물들에 의한 ROS 억제 활성은 세포 내에서 증가된 ROS가 DCF-DA와 반응하면 녹색형광으로 관찰되는 원리를 이용하였다. RAW 264.7 세포에 LPS를 처리하여 산화적 스트레스를 유발시킨 후 흑마늘, 흑삼 및 3종 혼합 추출물들에 의한 ROS 생성 억제를 확인한 결과는 도 3과 같다. 도 3에서, 모든 시료 값은 동일한 조건으로 3회 반복실험을 한 결과에 대한 평균±편차 값으로 표시하였다. (*, p<0.05; **, p<0.01; ***, p<0.001)The ROS inhibitory activity by the five extracts used the principle of green fluorescence observed when ROS increased in cells reacted with DCF-DA. The results of confirming the inhibition of ROS production by black garlic, black ginseng, and three types of mixed extracts after induced oxidative stress by treating RAW 264.7 cells with LPS are shown in FIG. 3 . In FIG. 3 , all sample values were expressed as mean±deviation values for the results of three repeated experiments under the same conditions. (*, p<0.05; **, p<0.01; ***, p<0.001)

도 3을 참조해보면, Fluorescence microplate reader를 이용하여 DCF-DA로 염색한 세포를 분석한 결과 시료 5종 모두가 800 μg/mL 농도에서 ROS의 생성을 유의적으로 감소시켰다(p<0.05). 앞선 NO 생성 억제에서와 동일하게 800 μg/mL 농도에서 흑삼 추출물의 ROS 생성량 억제율이 가장 높았고 그 다음으로 Mix 3의 순이었다. Referring to FIG. 3 , as a result of analyzing cells stained with DCF-DA using a fluorescence microplate reader, all five samples significantly reduced ROS generation at a concentration of 800 μg/mL (p<0.05). As in the previous inhibition of NO production, the ROS production inhibition rate of black ginseng extract was the highest at 800 μg/mL concentration, followed by Mix 3.

(4) Phosphodiesterase(PDE) 저해 효과 측정(4) Phosphodiesterase (PDE) inhibitory effect measurement

PDE 저해 효과는 cyclic nucleotide phosphodiesterase assay kit을 이용하여 측정하였다. 3,5-cGMP를 기질(20μL)로 하여 PDE(4 mU/μL) 5 μL와 각각의 추출물들을 10 μL씩 첨가하여 반응시킨 다음 5-nucleotidase 10 μL로 처리하고 혼합하였다. BIOMOL GREEN reagent 100 μL를 처리하여 실온에서 30분간 반응시킨 후 620 nm에서 흡광도를 측정하였다. 5-GMP는 표준곡선을 사용하여 PDE inhibition(%)으로 나타내었다.The PDE inhibitory effect was measured using a cyclic nucleotide phosphodiesterase assay kit. Using 3,5-cGMP as a substrate (20 μL), 5 μL of PDE (4 mU/μL) and 10 μL of each extract were added and reacted, then treated with 10 μL of 5-nucleotidase and mixed. 100 μL of BIOMOL GREEN reagent was treated and reacted at room temperature for 30 minutes, and then absorbance was measured at 620 nm. 5-GMP was expressed as PDE inhibition (%) using a standard curve.

음경이 발기할 때 cGMP는 혈관을 확장시키는 역할을 하는데 이것은 PDE에 의해 분해된다. 따라서 PDE의 활성을 억제하여 cGMP의 농도가 증가해야 발기능이 향상된다고 알려져 있다. 이러한 관점에서 흑마늘가 흑삼 추출물 및 이들의 혼합물 3종이 발기력 유지에 미치는 영향을 평가하고자 PDE 억제 활성을 평가한 결과는 도 4와 같다. 도 4에서, 모든 시료 값은 동일한 조건으로 3회 반복실험을 한 결과에 대한 평균±편차 값으로 표시하였다. (대조군과 비교하였을 때 *P < 0.05, **P < 0.01 and ***P < 0.001) When the penis is erect, cGMP acts to dilate blood vessels, which is broken down by PDE. Therefore, it is known that erectile function is improved only when the concentration of cGMP is increased by inhibiting the activity of PDE. From this point of view, the results of evaluating PDE inhibitory activity in order to evaluate the effect of black garlic black ginseng extract and three mixtures thereof on maintaining erection are shown in FIG. 4 . In FIG. 4 , all sample values were expressed as mean±deviation values for the results of three repeated experiments under the same conditions. (*P < 0.05, **P < 0.01 and ***P < 0.001 compared to control)

도 4를 참조해보면, 추출물들을 800 μg/mL 농도로 처리하였을 때 PDE의 저해율은 흑마늘 추출분말의 경우 대조군 대비 95.54%, 흑삼의 경우 70.81% 증가하였다. 혼합물 3종 중에서는 흑마늘의 함량비가 가장 높은 Mix 1이 73.06%로 PDE 저해율이 높게 측정되었으며, 다른 혼합물들도 흑삼 추출물 단독 처리군과 유사한 범위에서 활성이 확인되었다.Referring to FIG. 4 , when the extracts were treated at a concentration of 800 μg/mL, the inhibition rate of PDE was increased by 95.54% in the case of black garlic extract powder compared to the control group, and by 70.81% in the case of black ginseng. Among the three mixtures, Mix 1, which had the highest content ratio of black garlic, had a high PDE inhibition rate of 73.06%, and other mixtures were also confirmed to have similar activity to the group treated with black ginseng extract alone.

(5) TM3 세포 증식에 대한 세포독성(5) Cytotoxicity to TM3 cell proliferation

TM3 세포는 고환에서 대표적인 남성호르몬인 testosteron을 생성하는 세포이다. 본 발명의 주 원료인 흑마늘 추출물과 부재료인 흑삼 추출물 그리고 이들의 조성물이 남성호르몬 분비에 미치는 영향을 분석하고자 세포독성을 먼저 평가하였다. TM3 cells are cells that produce testosteron, a representative male hormone in the testis. Cytotoxicity was first evaluated to analyze the effect of black garlic extract, which is the main raw material of the present invention, black ginseng extract, which is a subsidiary material, and their composition on male hormone secretion.

Leydig 세포인 TM3 세포는 10%(v/v) fetal bovine serum(FBS), penicillin (100 U/mL), streptomycin (100 μg/mL)을 첨가한 DMEM 배지에서 37℃, 5% CO2로 유지하면서 배양하였다. 96 well plate에 세포농도 2.5×105 cells/mL로 분주한 다음 세포부착을 위해 24시간 배양한 후 시료를 농도별로 처리하여 세포의 cytotoxicity를 확인하였다. 세포 생존율은 MTT assay를 이용해 측정하였다. 570 nm에서 흡광도를 측정하고, 측정 결과는 무처리군의 세포 생존율과 비교하여 백분율로 나타내었다.Leydig cells, TM3 cells, were maintained at 37°C and 5% CO 2 in DMEM medium supplemented with 10% (v/v) fetal bovine serum (FBS), penicillin (100 U/mL), and streptomycin (100 μg/mL). while culturing. Cells were aliquoted at a cell concentration of 2.5 × 10 5 cells/mL in a 96-well plate, and then cultured for 24 hours for cell adhesion. Samples were treated by concentration to confirm cell cytotoxicity. Cell viability was measured using MTT assay. Absorbance was measured at 570 nm, and the measurement result was expressed as a percentage compared to the cell viability of the untreated group.

흑마늘, 흑삼 및 Mix 3종의 세포 생존율을 확인하기 위하여 TM3 세포를 대상으로 MTT assay를 진행한 결과는 도 5와 같다. 실험된 모든 시료가 실험된 최고 농도인 800 μg/mL 농도까지는 무처리 대조군에 비해 유의성 있는 생존율의 감소는 유발되지 않았으므로 이 이하의 농도에서 이하 실험이 진행되었다. 농도별 추출물 5종의 TM3 세포에 대한 생존율 평가 결과는 도 5와 같으며, 여기서 모든 시료 값은 동일한 조건으로 3회 반복실험을 한 결과에 대한 평균±편차 값으로 표시하였다.In order to confirm the cell viability of black garlic, black ginseng, and Mix 3, the results of MTT assay on TM3 cells are shown in FIG. 5 . All the tested samples did not cause a significant decrease in survival rate compared to the untreated control up to the highest concentration of 800 μg/mL, so the following experiments were conducted at concentrations below this level. The viability evaluation results for the TM3 cells of 5 types of extracts by concentration are shown in FIG. 5 , where all sample values are expressed as mean±deviation values for the results of three repeated experiments under the same conditions.

(6) TM3 세포의 세포보호 효과 및 세포내 testosterone 함량(6) Cytoprotective effect of TM3 cells and intracellular testosterone content

TM3 세포보호능 측정은 과산화수소로 TM3 세포에 산화적 스트레스를 주어 추출물의 보호 효과를 측정하였다. TM3 세포는 48 wells plate에 1×105 cells/well의 세포를 분주하여 24시간 동안 배양한 후 배지를 제거하고 추출물이 용해된 serum이 3% 함유된 배지 0.5 mL를 분주하고 24시간 배양하였다. 배양액 제거 후 300 μM의 과산화수소와 추출물이 함유된 배양액을 분주하고 24시간 동안 배양한 후 배지를 제거하였다. 세포보호 효과는 MTT assay를 이용해 측정하였다. 570 nm에서 흡광도를 측정하고, 측정 결과는 300 μM의 과산화수소 처리군의 세포 생존율과 비교하여 백분율로 나타내었다.To measure TM3 cell protection, oxidative stress was applied to TM3 cells with hydrogen peroxide to measure the protective effect of the extract. TM3 cells were cultured for 24 hours by dispensing 1×10 5 cells/well cells in a 48 wells plate, removing the medium, and dispensing 0.5 mL of a medium containing 3% serum in which the extract was dissolved and cultured for 24 hours. After removal of the culture medium, a culture solution containing 300 μM hydrogen peroxide and extract was dispensed and cultured for 24 hours, after which the medium was removed. The cytoprotective effect was measured using the MTT assay. Absorbance was measured at 570 nm, and the measurement result was expressed as a percentage compared to the cell viability of the 300 μM hydrogen peroxide treatment group.

TM3 세포 내 testosterone 함량은 TM3 세포 배양액으로 측정하였다. TM3 세포는 48 wells plate에 1×105 cells/well의 세포를 분주하여 24시간 동안 배양한 후 배지를 제거하고 추출물이 농도별로 처리된 배지 0.5 mL를 분주하고 3일 동안 배양하였다. 배양이 끝난 후 배지는 assay kit을 사용하여 testosterone 함량을 측정하였다. 배지 100 μL를 goat anti-mouse IgG microtiter plate에 옮긴 다음 testosterone EIA antibody 50 μL를 첨가하여 1시간 배양하고 conjugate 50 μL를 첨가하여 1시간 동안 배양한 후 washing solution으로 세척하였다. 각각에 pNpp substrate solution 200 μL를 첨가하여 1시간 동안 반응한 후 stop solution 50 μL를 넣어 반응을 중지시키고 405 nm에서 흡광도를 측정하여 testosterone 표준 곡선을 이용하여 함량을 계산하였다.Testosterone content in TM3 cells was measured with TM3 cell culture medium. TM3 cells were cultured for 24 hours by dispensing 1×10 5 cells/well of cells in a 48 wells plate, removing the medium, and dispensing 0.5 mL of medium treated with extracts by concentration, and incubating for 3 days. After the culture was completed, the testosterone content of the medium was measured using an assay kit. Transfer 100 μL of medium to goat anti-mouse IgG microtiter plate, add 50 μL of testosterone EIA antibody, incubate for 1 hour, add 50 μL of conjugate, incubate for 1 hour, and wash with washing solution. 200 μL of pNpp substrate solution was added to each, and after reaction for 1 hour, 50 μL of stop solution was added to stop the reaction, and absorbance was measured at 405 nm to calculate the content using a testosterone standard curve.

TM3 세포에 5종의 추출물들을 각각 100, 200, 400, 800 μg/mL 농도로 처리하고 3일 동안 배양시킨 후 세포에서 배양액에 분비된 testosterone 함량을 측정하였다(도 7). 그 결과 무처리군에서 testosterone 함량은 0.86 ng/mL인 반면에 800 μg/mL의 흑삼 추출물을 처리한 경우 3.09 ng/mL으로 3.59배 증가하였다. 그리고 3종 혼합물에서 흑삼의 비율이 높아질수록 testosterone의 함량이 증가하였다.Five types of extracts were treated in TM3 cells at concentrations of 100, 200, 400 and 800 μg/mL, respectively, and after culturing for 3 days, the content of testosterone secreted from the cells into the culture was measured ( FIG. 7 ). As a result, the testosterone content in the untreated group was 0.86 ng/mL, whereas in the case of 800 μg/mL black ginseng extract, it increased 3.59 times to 3.09 ng/mL. And as the ratio of black ginseng increased in the three types of mixture, the content of testosterone increased.

5종 추출물들이 산화적 스트레스에 대한 방어 효과와 testosterone 생산이 저하되어 나타나는 증상을 완화할 수 있는지를 알아보기 위해 TM3 세포에서 과산화수소에 대한 세포보호능과 testosterone 함량에 어떤 영향을 미치는지 평가한 결과는 각각 도 6과 도 7에 나타내었다. The results of evaluating the effects of the five extracts on the cytoprotective ability against hydrogen peroxide and the testosterone content in TM3 cells to determine whether the five extracts can alleviate the symptoms of decreased testosterone production and the protective effect against oxidative stress, respectively. 6 and 7 are shown.

도 6에서, 모든 시료 값은 동일한 조건으로 3회 반복실험을 한 결과에 대한 평균±편차 값으로 표시하였음. * 표시는 대조군에 대한 P < 0.05 범위에서 유의차가 있고, 도 7에서 모든 시료 값은 동일한 조건으로 3회 반복실험을 한 결과에 대한 평균±편차 값으로 표시하였으며, 대조군과 비교하여 *표시는 P < 0.05에서 ** 표시는 P < 0.01 범위에서 유의차가 있다.In FIG. 6 , all sample values were expressed as mean±deviation values for the results of three repeated experiments under the same conditions. * indicates that there is a significant difference in the range of P < 0.05 for the control group, and in FIG. 7 , all sample values are expressed as the mean±deviation value for the results of three repeated experiments under the same conditions, and compared with the control group, * indicates P In < 0.05, ** marks have a significant difference in the range of P < 0.01.

도 6을 참조해보면, TM3 세포에 0.3 mM 과산화수소를 처리하여 산화적 스트레스를 유도시킨 후 5종 추출물들을 100, 200, 400, 800 μg/mL 농도로 처리한 결과 과산화수소만 처리한 군은 무처리군보다 세포생존율이 32.47% 감소하였다. 반면 5종 추출물들을 각각 800 μg/mL씩 처리한 경우는 과산화수소만 처리한 군에 비해 상대적으로 높은 세포보호능을 나타내었다.Referring to FIG. 6 , after inducing oxidative stress by treating TM3 cells with 0.3 mM hydrogen peroxide, the five extracts were treated at concentrations of 100, 200, 400, and 800 μg/mL. As a result, the group treated with only hydrogen peroxide was the untreated group. The cell viability was reduced by 32.47%. On the other hand, the case where each of the five extracts was treated at 800 μg/mL showed a relatively high cytoprotective ability compared to the group treated with only hydrogen peroxide.

도 7을 참조해보면, TM3 세포는 고환의 간질에서 콜레스테롤을 testosterone으로 합성하는 세포로 활성산소의 자극에 의해 testosterone 감소 및 세포생존율이 감소한다. 이런 testosterone 및 세포생존율 감소는 발기능 저하로 이어진다. Referring to FIG. 7 , TM3 cells are cells that synthesize cholesterol into testosterone in the interstitium of the testis, and testosterone reduction and cell viability are reduced by stimulation of reactive oxygen species. This decrease in testosterone and cell viability leads to decreased erectile function.

5종의 추출물들은 과산화수소에 의한 TM3 세포의 산화적 스트레스에 대해 세포 보호효과를 가지고 있기 때문에 이를 통해 testosterone 함량을 증가시키는 결과가 나타났다고 판단된다. 이러한 결과는 산화적 스트레스로 유도된 세포 손상 및 testosterone 수치 감소가 추출물 처리 시에 개선되었으며 추출물들이 고환 내 세포의 산화적 스트레스를 억제시켜 세포 내 호르몬합성이 증가된다는 연구와 일치한다. 따라서 이러한 전립선 비대증 치료제로 사용되는 finasteride를 복용했을 때 나타나는 발기부전과 같은 부작용과 testosterone 함량 감소로 나타나는 증상을 완화할 수 있을 것이라 판단된다.Since the five extracts have a cytoprotective effect against the oxidative stress of TM3 cells caused by hydrogen peroxide, it is judged that the result of increasing the testosterone content was shown. These results are consistent with the study that oxidative stress-induced cell damage and testosterone levels were improved when the extract was treated, and that the extracts suppressed oxidative stress in testicular cells and increased intracellular hormone synthesis. Therefore, it is judged that side effects such as erectile dysfunction and symptoms caused by a decrease in testosterone content can be alleviated when finasteride, which is used as a treatment for benign prostatic hyperplasia, is taken.

이상의 설명은 본 발명을 예시적으로 설명한 것에 불과한 것으로, 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자라면 본 발명의 본질적인 특성에서 벗어나지 않은 범위에서 다양한 수정 및 변형이 가능할 것이다. 따라서, 본 발명에 개시된 실시예들은 본 발명의 기술사상을 한정하기 위한 것이 아니라 설명하기 위한 것이고, 이러한 실시예에 의하여 본 발명의 기술 사상의 범위가 한정되는 것은 아니다. 본 발명의 보호 범위는 아래의 청구범위에 의하여 해석되어야 하며, 그와 동등하거나 균등한 범위 내에 있는 모든 기술사상은 본 발명의 권리범위에 포함되는 것으로 해석되어야 할 것이다.The above description is merely illustrative of the present invention, and various modifications and variations will be possible without departing from the essential characteristics of the present invention by those skilled in the art to which the present invention pertains. Therefore, the embodiments disclosed in the present invention are not intended to limit the technical spirit of the present invention, but to explain, and the scope of the technical spirit of the present invention is not limited by these embodiments. The protection scope of the present invention should be construed by the following claims, and all technical ideas that are equivalent to or within the equivalent range should be construed as being included in the scope of the present invention.

Claims (6)

흑마늘 추출물, 벌꿀 및 흑삼분말로 이루어지며,
총페놀화합물 함량이 130 ㎍/g 이상이고, 콜레스테롤 흡착활성이 50% 이상인 남성 건강증진용 조성물로서,
상기 흑마늘 추출물:벌꿀:흑삼분말의 중량비는 80:15:5이며,
상기 흑마늘 추출물은, 흑마늘 무게 대비 3~4배의 물을 가한 후, 90~95℃에서 400~430분간 추출하여 얻어진 20 brix의 흑마늘 추출물을 30 brix로 농축한 것으로,
상기 20 brix의 흑마늘 추출물에 함유된 총페놀화합물은 99 mg/100g 이상이고, S-allyl-cysteine은 12 mg/100g 이상인 것을 특징으로 하는 남성 건강증진용 조성물.
It consists of black garlic extract, honey and black ginseng powder.
A composition for promoting male health with a total phenolic compound content of 130 μg/g or more and a cholesterol adsorption activity of 50% or more,
The weight ratio of the black garlic extract: honey: black ginseng powder is 80:15:5,
The black garlic extract was concentrated to 30 brix of 20 brix of black garlic extract obtained by adding 3 to 4 times the weight of black garlic, followed by extraction at 90 to 95 ° C. for 400 to 430 minutes,
The composition for men's health promotion, characterized in that the total phenolic compounds contained in the 20 brix black garlic extract is 99 mg/100g or more, and the S-allyl-cysteine is 12 mg/100g or more.
제 1항에 있어서,
상기 흑마늘 추출물은 92.7℃에서 412분간 추출한 것을 특징으로 하는 남성 건강증진용 조성물.
The method of claim 1,
The black garlic extract is a composition for men's health promotion, characterized in that it is extracted at 92.7 ℃ for 412 minutes.
삭제delete 삭제delete 삭제delete 삭제delete
KR1020190104204A 2019-08-26 2019-08-26 Black garlic extract, black garlic drink comprising it and composition for improving male health comprising it KR102353048B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020190104204A KR102353048B1 (en) 2019-08-26 2019-08-26 Black garlic extract, black garlic drink comprising it and composition for improving male health comprising it

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020190104204A KR102353048B1 (en) 2019-08-26 2019-08-26 Black garlic extract, black garlic drink comprising it and composition for improving male health comprising it

Publications (2)

Publication Number Publication Date
KR20210024726A KR20210024726A (en) 2021-03-08
KR102353048B1 true KR102353048B1 (en) 2022-01-18

Family

ID=75184858

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020190104204A KR102353048B1 (en) 2019-08-26 2019-08-26 Black garlic extract, black garlic drink comprising it and composition for improving male health comprising it

Country Status (1)

Country Link
KR (1) KR102353048B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220169089A (en) 2021-06-18 2022-12-27 엠케이바이오파낙스 주식회사 Health supplement composition using Hwangchil wood and black garlic, and its manufacturing method and product

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101788253B1 (en) * 2017-01-18 2017-10-19 (주) 나일랜드 Composition for improving male sexual function comprising the extract of Alpinia Officinarum, Smilacina Japonica & Black Garlic

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120019988A (en) * 2010-08-27 2012-03-07 웅진식품주식회사 Drink composition comprising a black galic and a fermented red ginseng, and method of preparing the same
KR20180105361A (en) * 2017-03-15 2018-09-28 (재)남해마늘연구소 Drink composition comprising a Black Galic and a Red Ginseng and method of making the same
KR20180136680A (en) * 2017-06-15 2018-12-26 남해보물섬마늘영농조합법인 Method of producing a black garlic drink containing herbal medicine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101788253B1 (en) * 2017-01-18 2017-10-19 (주) 나일랜드 Composition for improving male sexual function comprising the extract of Alpinia Officinarum, Smilacina Japonica & Black Garlic

Also Published As

Publication number Publication date
KR20210024726A (en) 2021-03-08

Similar Documents

Publication Publication Date Title
Attar et al. In vitro antioxidant, antidiabetic, antiacetylcholine esterase, anticancer activities and RP-HPLC analysis of phenolics from the wild bottle gourd (Lagenaria siceraria (Molina) Standl.)
Montoro et al. Evaluation of bioactive compounds and antioxidant capacity of edible feijoa (Acca sellowiana (O. Berg) Burret) flower extracts
Gonçalves et al. Bioactive properties of Chamaerops humilis L.: antioxidant and enzyme inhibiting activities of extracts from leaves, seeds, pulp and peel
Zhang et al. Nelumbo nucifera leaf extracts inhibit the formation of advanced glycation end-products and mechanism revealed by Nano LC-Orbitrap-MS/MS
KR102353048B1 (en) Black garlic extract, black garlic drink comprising it and composition for improving male health comprising it
KR102105111B1 (en) Energy drink composition containing increased biological active materials and preparation method thereof
Güven et al. Food plant with antioxidant, tyrosinase inhibitory and antimelanoma activity: Prunus mahaleb L
Terzić et al. Could elderberry fruits processed by modern and conventional drying and extraction technology be considered a valuable source of health-promoting compounds?
Kim et al. Enhancing the organoleptic and functional properties of jujube by a quick aging process
KR102298700B1 (en) Facturing method of functional liquefied healthfoods using Gastroia elata Blume and Polygonum multiflorum Thunberg
KR101661491B1 (en) Method of manufacturing vegetable juice with improved health functions using Allium Hookeri
KR101025766B1 (en) The manufacturing method and the korean traditional herb tea composition for inhibiting obesity
KR20200042325A (en) Liquid composition for stick-type container comprising active mountain-cultivated ginseng extract having increased ginsenosides of human body absorption type, and preparation method thereof
KR20220095075A (en) Anti-inflammation composition, Health functional food containing the same and Pharmaceutical composition containing the same
KR101403355B1 (en) Method for producing dandelion flower Sikhae
KR102048623B1 (en) A composition comprising acidic polysaccharide in red ginseng marc and method thereof
KR101292313B1 (en) The manufacturing method of black jujube
Lee et al. Extraction and chromatographic separation of anticarcinogenic fractions from cacao bean husk
KR20210050103A (en) Immune enhancing liquid composition having increased ginsenosides Rb1, Rg1 and Rg3 and preparation method thereof
KR100719965B1 (en) Method for preparing kochujang with arctium laooa
Choi et al. Comparison of quality and bioactive components of Korean green, white, and black teas and their associated GABA teas
KR101610737B1 (en) Method for preparing Vinegar added with the Fruit of Akebia quinata having anti-oxidative, Vinegar manufactured by this method, and the functional foodcomposition comprising the same
KR102671778B1 (en) Method for producing broccoli powder with enhanced glucoraphanin content
KR102514074B1 (en) Fermented pomegranate composition for improving vascular health, prostate or sexual function, containing high content of ellagic acid and gallic acid with increased absorption into the body and its use having skin whitening, wrinkle improvement or antioxidant function, and method for manufacturing the same by using EFC method
KR100581532B1 (en) Method for water extracts of Hericium erinaceus, and soup thereof

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant